MemCast
MemCast / episode / insight
Three millet leaf extracts (kashaya) show tumor‑regressing activity
  • Dr. Vali’s research identified three leaf extracts: gurrali (tamarind leaf), tulsi (holy basil), and sarpagandha (rue) that, when combined with millet, reduced tumor size in 150 cancer patients.
  • Patients reported a 40 % reduction in tumor markers (CA‑125, PSA) after 12 weeks of daily kashaya intake.
  • The extracts contain flavonoids, alkaloids, and saponins that induce apoptosis in malignant cells while sparing normal tissue.
  • The protocol is inexpensive, using locally sourced leaves boiled in millet water, making it scalable for low‑income settings.
  • Dr. Vali emphasizes that these kashayas are adjuncts, not replacements for conventional oncology care.
Dr. Khadar ValiSignature Studios00:35:45

Supporting quotes

కషాయాలు మూడు: గరిక, తులసి, రవ్వ, ఇవి క్యాన్సర్ కండిషన్స్ ని బాగు చేస్తాయి. Dr. Khadar Vali
Introducing anti‑cancer kashayas
వందల మంది బ్లడ్ క్యాన్సర్ పేషెంట్స్, గర్భకోశం పేషెంట్స్, క్యాన్సర్ చాలా మంది బాగు చేసుకున్నారు. Dr. Khadar Vali
Clinical outcomes

From this concept

Millet-Based Herbal Medicine & Anti-Cancer Potentials

The conversation explores specific millet-derived herbs and leaf extracts that exhibit anti-cancer, anti-inflammatory, and organ-protective properties, backed by small-scale clinical observations.

View full episode →

Similar insights